Mitemcinal Fumarate

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameMitemcinal Fumarate
Drug Alias Name米坦西那Mitemcinal-FumaratemitemcinalGM-611
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMotilin receptor agonists
TargetsMotilin receptor
Therapy Area/IndicationsGastroparesis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChugai Pharma USA, Inc
Active IndicationsN/A
Inactive IndicationsGastroparesis

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG